Mackenzie Financial’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q4 | – | Sell |
-39,900
| Closed | -$125K | – | 1034 |
|
2020
Q3 | $125K | Hold |
39,900
| – | – | ﹤0.01% | 942 |
|
2020
Q2 | $73K | Hold |
39,900
| – | – | ﹤0.01% | 975 |
|
2020
Q1 | $40K | Hold |
39,900
| – | – | ﹤0.01% | 1048 |
|
2019
Q4 | $111K | Hold |
39,900
| – | – | ﹤0.01% | 1054 |
|
2019
Q3 | $61K | Hold |
39,900
| – | – | ﹤0.01% | 993 |
|
2019
Q2 | $83K | Hold |
39,900
| – | – | ﹤0.01% | 1075 |
|
2019
Q1 | $143K | Hold |
39,900
| – | – | ﹤0.01% | 1192 |
|
2018
Q4 | $153K | Hold |
39,900
| – | – | ﹤0.01% | 1101 |
|
2018
Q3 | $377K | Hold |
39,900
| – | – | ﹤0.01% | 942 |
|
2018
Q2 | $291K | Hold |
39,900
| – | – | ﹤0.01% | 894 |
|
2018
Q1 | $200K | Hold |
39,900
| – | – | ﹤0.01% | 906 |
|
2017
Q4 | $201K | Hold |
39,900
| – | – | ﹤0.01% | 797 |
|
2017
Q3 | $247K | Hold |
39,900
| – | – | ﹤0.01% | 577 |
|
2017
Q2 | $144K | Hold |
39,900
| – | – | ﹤0.01% | 600 |
|
2017
Q1 | $130K | Hold |
39,900
| – | – | ﹤0.01% | 615 |
|
2016
Q4 | $98K | Hold |
39,900
| – | – | ﹤0.01% | 627 |
|
2016
Q3 | $137K | Hold |
39,900
| – | – | ﹤0.01% | 622 |
|
2016
Q2 | $139K | Hold |
39,900
| – | – | ﹤0.01% | 898 |
|
2016
Q1 | $165K | Hold |
39,900
| – | – | ﹤0.01% | 775 |
|
2015
Q4 | $178K | Hold |
39,900
| – | – | ﹤0.01% | 786 |
|
2015
Q3 | $243K | Hold |
39,900
| – | – | ﹤0.01% | 753 |
|
2015
Q2 | $473K | Hold |
39,900
| – | – | ﹤0.01% | 682 |
|
2015
Q1 | $697K | Buy |
+39,900
| New | +$697K | ﹤0.01% | 600 |
|